Cited by 209Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCerebrovascular and genetic disorders

Neurofilament protein in cerebrospinal fluid: A marker of white matter changes

Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L.‐O., Edman, Å, Lind, K., Rosengren, L., Blennow, K. +1 more·2001·Journal of Neuroscience Research

Abstract

The objective of this study was to compare cerebrospinal fluid (CSF) levels of the light subtype of the neurofilament proteins (NFL), tau, and beta-amyloid42 (Abeta42) in individuals with moderate or severe white matter changes (WMC) and in those with mild or no WMC. Twenty-two patients with Alzheimer's disease (AD), nine patients with subcortical vascular dementia (SVD), and 20 normal controls were included in the study. The occurrence of WMC was evaluated by a neuroradiologist using the Blennow-Wallin scale. Thirty-seven subjects had no or only punctate WMC; 14 had moderate to severe WMC. Both diagnostic group and WMC, but not gender or apolipoproteinE E4 inheritance, contributed to the variance in the CSF levels of tau, NFL, and Abeta42. In patients with moderate to severe WMC, CSF NFL (P < 0.01), but not CSF tau or CSF Abeta42, was increased also after correction for age, gender, and degree of cognitive impairment. A comparison between patients and controls with any signs of WMC and those without such signs yielded a similar result: CSF NFL (P < 0.001) was increased in the group with signs of WMC. As in numerous previous studies, we found that CSF tau was increased in AD (P < 0.001) compared with controls. Furthermore, CSF NFL was increased in both AD and SVD compared with controls (P < 0.001 for both). Although diagnostic group seems to be a stronger predictor of the variance found in CSF NFL, a clear association between the presence of WMC and increased CSF NFL was foun…

Integrity signals

Registry

Crossref · 10.1002/jnr.1242

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • NFL is a potential biomarker of WM damage.

    “Since NFL is a potential biomarker of WM damage (Sjogren et al., 2001), we hypothesized that the levels of NFL would increase in mouse model of Aβ amyloidosis.”

    From Disrupted structural connectivity in ArcAβ mouse model of Aβ amyloidosis (2020) · cites this paper as Sjogren et al., 2001

The citation lists haven’t been fetched yet

References 60 · Cited by 209

Authors
Sjögren, M., Blomberg, M., Jonsson, M., Wahlund, L. ‐., Edman, Å., Lind, K., Rosengren, L., Blennow, K., & Wallin, A.
Affiliations
  • University of Gothenburg (SE)
  • Swedish Research Council (SE)
Corresponding author
Sjögren, M.
Venue
Journal of Neuroscience Research
Publisher
Wiley
Published
2001-10-25
Volume
66
Issue
3
Pages
510-516
ISSN
  • 0360-4012 (ISSN-L)
  • 1097-4547
OpenAlex
W1977206425
Cited by
209
References
60
Citations by year
2026: 3 · 2025: 5 · 2024: 11 · 2023: 6 · 2022: 13 · 2021: 15 · 2020: 18 · 2019: 12 · 2018: 14 · 2017: 10 · 2016: 7 · 2015: 8 · 2014: 12 · 2013: 7 · 2012: 7
FWCI
4.29
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuroscience Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • The Alzheimer Foundation
  • Clas Groschinsky's Foundation
  • The Dementia Foundation
  • Edit Jacobsons donationsfond
  • Fredrik och Ingrid Thurings Stiftelse
  • Gun and Bertil Stohne's Foundation
  • Loo and Hans Osterman's Foundation for Medical Research
  • Martina och Wilhelm Lundgrens Stiftelse
  • Stiftelsen för Gamla Tjänarinnor
  • Stiftelsen Handlanden Hjalmar Svenssons Forskningsfond
  • Stiftelsen Lars Hiertas Minne
  • Lundbeckfonden
  • Pfannenstills forskningsfond
  • The Swedish Association of Neurologically Disabled
  • The Swedish Medical Society
  • The Swedish Research Council (12103, 11560, 12769, 13121, 09946)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
Keywords
neurofilament light chain, cerebrospinal fluid biomarkers, white matter changes, tau protein, Alzheimer's disease, subcortical vascular dementia, axonal degeneration, APOE ε4
MeSH terms
Aged, Alzheimer Disease, Apolipoproteins E, Cerebral Cortex, Diagnosis, Differential, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Nerve Fibers, Myelinated, Peptide Fragments, Predictive Value of Tests, Serum Albumin, Sex Factors, Wallerian Degeneration, Dementia, Vascular, Biomarkers, Amyloid beta-Peptides, tau Proteins, Neurofilament Proteins, Disease Progression, Apolipoprotein E4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review